433 related articles for article (PubMed ID: 35011670)
1. IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity.
Cayrol C
Cells; 2021 Dec; 11(1):. PubMed ID: 35011670
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
Cayrol C; Girard JP
Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
Cayrol C; Girard JP
Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage.
Scott IC; Majithiya JB; Sanden C; Thornton P; Sanders PN; Moore T; Guscott M; Corkill DJ; Erjefält JS; Cohen ES
Sci Rep; 2018 Feb; 8(1):3363. PubMed ID: 29463838
[TBL] [Abstract][Full Text] [Related]
5. [Interleukin-33: from biology to potential treatments].
Schmitt P; Girard JP; Cayrol C
Med Sci (Paris); 2019 May; 35(5):440-451. PubMed ID: 31115327
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Invariant NKT Cells in Sterile Inflammation: The Possible Contribution of the Alarmin/Cytokine IL-33.
Ferhat MH; Robin A; Barbier L; Thierry A; Gombert JM; Barbarin A; Herbelin A
Front Immunol; 2018; 9():2308. PubMed ID: 30374349
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 33 is a guardian of barriers and a local alarmin.
Martin NT; Martin MU
Nat Immunol; 2016 Feb; 17(2):122-31. PubMed ID: 26784265
[TBL] [Abstract][Full Text] [Related]
8. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
Front Immunol; 2018; 9():2004. PubMed ID: 30233590
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
Chen WY; Tsai TH; Yang JL; Li LC
Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
[TBL] [Abstract][Full Text] [Related]
10. Dichotomous function of IL-33 in health and disease: From biology to clinical implications.
Braun H; Afonina IS; Mueller C; Beyaert R
Biochem Pharmacol; 2018 Feb; 148():238-252. PubMed ID: 29309756
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-33 and Behçet disease: Another cytokine among others.
Hamzaoui K; Bouali E; Hamzaoui A
Hum Immunol; 2015 May; 76(5):301-6. PubMed ID: 25814446
[TBL] [Abstract][Full Text] [Related]
12. New perspectives on IL-33 and IL-1 family cytokines as innate environmental sensors.
Scott IC; Rees DG; Cohen ES
Biochem Soc Trans; 2018 Oct; 46(5):1345-1353. PubMed ID: 30301844
[TBL] [Abstract][Full Text] [Related]
13. IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.
Chan BCL; Lam CWK; Tam LS; Wong CK
Front Immunol; 2019; 10():364. PubMed ID: 30886621
[TBL] [Abstract][Full Text] [Related]
14. Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review.
De Martinis M; Ginaldi L; Sirufo MM; Pioggia G; Calapai G; Gangemi S; Mannucci C
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32204562
[TBL] [Abstract][Full Text] [Related]
15. Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions.
Guo H; Bossila EA; Ma X; Zhao C; Zhao Y
Cells; 2022 Oct; 11(20):. PubMed ID: 36291105
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.
Schwartz C; O'Grady K; Lavelle EC; Fallon PG
Eur J Immunol; 2016 May; 46(5):1091-100. PubMed ID: 27000936
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cell alarmin cytokines: Frontline mediators of the asthma inflammatory response.
Duchesne M; Okoye I; Lacy P
Front Immunol; 2022; 13():975914. PubMed ID: 36311787
[TBL] [Abstract][Full Text] [Related]
18. T
Pascual-Reguant A; Bayat Sarmadi J; Baumann C; Noster R; Cirera-Salinas D; Curato C; Pelczar P; Huber S; Zielinski CE; Löhning M; Hauser AE; Esplugues E
Mucosal Immunol; 2017 Nov; 10(6):1431-1442. PubMed ID: 28198366
[TBL] [Abstract][Full Text] [Related]
19. IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease.
Perez F; Ruera CN; Miculan E; Carasi P; Dubois-Camacho K; Garbi L; Guzman L; Hermoso MA; Chirdo FG
Front Immunol; 2020; 11():581445. PubMed ID: 33133101
[TBL] [Abstract][Full Text] [Related]
20. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.
Lefrançais E; Duval A; Mirey E; Roga S; Espinosa E; Cayrol C; Girard JP
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15502-7. PubMed ID: 25313073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
